‘The time of the Einsteins is over’: Pharma urged to rethink trials for 2050
Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and fragmented patient engagement.
27 October 2025
27 October 2025
Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and fragmented patient engagement.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.